Head And Neck Cancer

Malnutrition, Decreased QOL Possible After Radiation Therapy for Head and Neck Cancer

Malnutrition, Decreased QOL Possible After Radiation Therapy for Head and Neck Cancer

By

In a retrospective study, researchers used established tools to measure the nutritional status of patients with head and neck cancer before, immediately after, and at 2 follow-up points after radiotherapy.

Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator

Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator

By

The head and neck oncology nurse navigator (ONN) is a unique and critical position to help patients, their families, and their caregivers as they face their diagnosis and undergo treatment.

Radiation-Induced Esophagitis: A Common, Debilitating Clinical Challenge in Thoracic Radiotherapy

Radiation-Induced Esophagitis: A Common, Debilitating Clinical Challenge in Thoracic Radiotherapy

By

A review of current options and ongoing trials for managing ARIE, a common esophageal adverse effect caused by radiotherapy to the thoracic region for lung, breast, or head and neck cancers, or lymphoma.

Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy

Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy

By

Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.

Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers

Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers

By

Study results presented at 2018 ASCO Annual Meeting demonstrated effectiveness of ado-trastuzumab emtansine in non-breast non-gastric HER2-amplified cancers.

Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes

Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes

By

A study presented at the 2018 ONS Annual Congress explored whether patients can safely bypass SICU after HNC surgery, transferring directly from PACU to a specialized unit within the SO.

Posttreatment Visual Function, Ocular Symptoms Impact QOL in Head and Neck Cancer

Posttreatment Visual Function, Ocular Symptoms Impact QOL in Head and Neck Cancer

By

A link between visual function, ocular symptoms, and quality of life was found in cross-sectional study of patients who underwent radiotherapy for head and neck cancers, according to a presentation at the 2018 ONS Annual Congress.

Dabrafenib-Trametinib Combination Approved for Mutation-Positive Thyroid Cancer

Dabrafenib-Trametinib Combination Approved for Mutation-Positive Thyroid Cancer

By

FDA grants approval to immunotherapy combination in the treatment of unresectable and metastatic BRAF V600E mutation-positive anaplastic thyroid cancer (ATC).

Long-term Impact of Retinoblastoma Therapy on Vision-Related Quality of Life

Long-term Impact of Retinoblastoma Therapy on Vision-Related Quality of Life

By

Using the NEI-VFQ-25, researchers assessed vision-targeted health-related quality of life for survivors of retinoblastoma.

Incidence, Age at Diagnosis Increasing in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

Incidence, Age at Diagnosis Increasing in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

By

A retrospective study demonstrates an increase in HPV16-positive status among patients with OPSCC and a corresponding increase in age at diagnosis.

Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases

Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases

By

Results of a retrospective review assessing the prevalence of chronic opioid use among patients with oropharynx cancer after surgery was presented at the 2018 American Head & Neck Society Annual Meeting.

HMB/Arg/Gln Does Not Reduce Oral Mucositis Incidence in Head and Neck Cancer

HMB/Arg/Gln Does Not Reduce Oral Mucositis Incidence in Head and Neck Cancer

By

In a phase 2 study, researchers sought to determine the effectiveness of adding HMB/Arg/Gln to cisplatin-based chemoradiotherapy for patients with head and cancers to prevent CRT-induced oral mucositis.

Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer

Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer

By

In a study from the Cleveland Clinic, researchers investigated the association between well-differentiated thyroid cancer and risk for AML or CML in those patients treated with radioactive iodine.

Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids

Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids

Researchers compared opioid use between head and neck cancer (HNCA) and lung or colon cancer (LCCA) cohorts.

Outcomes in SCCHN Improved With Swap of Docetaxel for 5-FU in Palliative Regimen

Outcomes in SCCHN Improved With Swap of Docetaxel for 5-FU in Palliative Regimen

By

Study results show the effect on high-grade toxicity when 5-FU is replaced with docetaxel in the EXTREME regimen in the palliative treatment of patients with metastatic SCCHN.

Preoperative Aspirin Use May Not Increase Risk of Bleeding in Thyroid Surgery

Preoperative Aspirin Use May Not Increase Risk of Bleeding in Thyroid Surgery

By

This study sought to determine if continuing preoperative aspirin therapy would increase the risk of bleeding complications in patients undergoing thyroid surgery.

Hot tea consumption associated with increased esophageal cancer risk in high-risk individuals

1. Hot tea consumption in combination with excessive smoking or alcohol use was associated with a higher risk for esophageal cancer. 2. In the absence of excessive alcohol use and smoking, daily tea drinking was not linked to increased risk for esophageal cancer. Evidence Rating Level: 1 (Excellent)      Study Rundown: Esophageal cancer is a concern []

Oral Impairment Linked to Reduced QOL in Posttherapy Head and Neck Cancer

Oral Impairment Linked to Reduced QOL in Posttherapy Head and Neck Cancer

By

Study compared the effect of treatments on quality of life in treatment-naïve patients with HNC vs those who underwent radiotherapy and/or chemotherapy, and compared with cancer-free patients.

Radiotherapy for Esophageal Carcinoma: Dose, Response and Survival

Radiotherapy for Esophageal Carcinoma: Dose, Response and Survival

[Cancer Management and Research] Radiation dose, fractionation strategies, and predictive factors of response to therapy in patients with esophageal carcinoma are reviewed to determine if more intense local therapy would lead to better outcomes and for which patients.

Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer

Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer

By

In this study, researchers sought to determine the effect depressive symptoms during treatment planning had on immediate and long-term outcomes for patients with head and neck cancer.

Lymph Node Density Helps Predict Thyroid Cancer Outcomes

Lymph Node Density Helps Predict Thyroid Cancer Outcomes

Papillary thyroid cancer patients with LND 0.19 have worse disease-specific, overall survival, researchers found.

Oral Microbiome Composition Linked to Esophageal Cancer Risk

Oral Microbiome Composition Linked to Esophageal Cancer Risk

Periodontal pathogen Tannerella forsythia linked to increased risk of esophageal adenocarcinoma

Survivors of Thyroid Cancer Have Higher Risk of Aging-related Morbidities

Survivors of Thyroid Cancer Have Higher Risk of Aging-related Morbidities

By

Using the statewide Utah Population Database, investigators sought to determine the long-term effects of thyroid cancer on survivors who were younger than 40 years at diagnosis.

Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC

Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC

By

Data on psychosocial and psychiatric variables of patients with HNC prior to treatment was analyzed to determine the extent of cognitive impairment and quality of life for patients with head and neck cancer, and its impact on patient outcomes.

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

By

Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.

Negative Margins, Lymph Node Yields Predict Survival

Negative Margins, Lymph Node Yields Predict Survival

Patients with head and neck cancer treated at hospitals attaining the combined metric of a 90 percent or higher negative margin rate and 80% percent of cases achieving a LNY of 18 or more experienced a significant reduction in mortality.

De-escalated Radiation Therapy Improves Quality of Life in Throat Cancer

De-escalated Radiation Therapy Improves Quality of Life in Throat Cancer

By

Aggressive de-escalation of chemoradiation after surgery in patients with HPV-associated OPSCC led to similar disease control and improved quality of life and safety profile compared with historical controls, according to data presented at the ASTRO 59th Annual Meeting.

Distress Assessments Improve Psychosocial Support Referrals for HNC Patients

Distress Assessments Improve Psychosocial Support Referrals for HNC Patients

By By By

A quality improvement project demonstrates that routine distress assessment using the NCCN DT/PL in patients with head and neck cancers improves referrals for psychosocial services.

Most Skull Radiation Patients Show No Cognitive Impairment

Most Skull Radiation Patients Show No Cognitive Impairment

The researchers found that the majority of patients had no frank detectable cognitive impairment after undergoing skull base irradiation.

Resistance Training, Nutritional Interventions Prevent Muscle Loss During, After Radiotherapy for Head and Neck Cancer

Resistance Training, Nutritional Interventions Prevent Muscle Loss During, After Radiotherapy for Head and Neck Cancer

By

Intervention with resistance training and nutritional supplements during and after radiation therapy is not only feasible, but also shown to prevent loss of muscle mass and improve quality of life in patients with head and neck cancer (HNC).

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs